Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rama S Verma

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
The Indian Journal of Medical Research|April 29, 2016
Breaking dogma for future therapy using stem cell - Where we have reached?Rama S Verma
Molecular Biology Reports|September 4, 2010
Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1Sirisha Potala, Rama S Verma
Analytical Biochemistry|June 21, 2011
Scanning electron microscopy preparation protocol for differentiated stem cellsSreejit Parameswaran, Rama S Verma
Cancer Science|May 23, 2009
Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapyMrudula Mathew, Rama S Verma
Journal of Biotechnology|June 29, 2010
Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterizationSirisha Potala, Rama S Verma
Current Opinion in Microbiology|June 1, 2012
Therapeutic targets and recent advances in protein immunotoxinsMadhumathi J, Rama S Verma
Cancer Letters|February 18, 2015
ROMO1 regulates RedOx states and serves as an inducer of NF-κB-driven EMT factors in Fanconi anemiaPavithra Shyamsunder, Rama S Verma, Alex Lyakhovich
Molecular Diagnosis & Therapy|February 7, 2017
SNAP-Tag Technology: A Promising Tool for Ex Vivo ImmunophenotypingSwati Choudhary, Stefan Barth, Rama S Verma
In Vitro Cellular & Developmental Biology. Animal|February 26, 2008
An improved protocol for primary culture of cardiomyocyte from neonatal miceP Sreejit, Suresh Kumar, Rama S Verma
Drug Discovery Today|April 23, 2011
Therapeutic potential of anticancer immunotoxinsSwati Choudhary, Mrudula Mathew, Rama S Verma
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
The Indian Journal of Medical Research|April 29, 2016
Breaking dogma for future therapy using stem cell - Where we have reached?Rama S Verma
Molecular Biology Reports|September 4, 2010
Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1Sirisha Potala, Rama S Verma
Analytical Biochemistry|June 21, 2011
Scanning electron microscopy preparation protocol for differentiated stem cellsSreejit Parameswaran, Rama S Verma
Cancer Science|May 23, 2009
Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapyMrudula Mathew, Rama S Verma
Journal of Biotechnology|June 29, 2010
Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterizationSirisha Potala, Rama S Verma
Current Opinion in Microbiology|June 1, 2012
Therapeutic targets and recent advances in protein immunotoxinsMadhumathi J, Rama S Verma
Cancer Letters|February 18, 2015
ROMO1 regulates RedOx states and serves as an inducer of NF-κB-driven EMT factors in Fanconi anemiaPavithra Shyamsunder, Rama S Verma, Alex Lyakhovich
Molecular Diagnosis & Therapy|February 7, 2017
SNAP-Tag Technology: A Promising Tool for Ex Vivo ImmunophenotypingSwati Choudhary, Stefan Barth, Rama S Verma
In Vitro Cellular & Developmental Biology. Animal|February 26, 2008
An improved protocol for primary culture of cardiomyocyte from neonatal miceP Sreejit, Suresh Kumar, Rama S Verma
Drug Discovery Today|April 23, 2011
Therapeutic potential of anticancer immunotoxinsSwati Choudhary, Mrudula Mathew, Rama S Verma
Pageof 5